156 related articles for article (PubMed ID: 17290045)
1. Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease.
Droemann D; Rupp J; Goldmann T; Uhlig U; Branscheid D; Vollmer E; Kujath P; Zabel P; Dalhoff K
Am J Respir Crit Care Med; 2007 Apr; 175(8):791-7. PubMed ID: 17290045
[TBL] [Abstract][Full Text] [Related]
2. Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD.
Brandén E; Koyi H; Gnarpe J; Gnarpe H; Tornling G
Respir Med; 2005 Jan; 99(1):20-6. PubMed ID: 15672844
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD).
Karnak D; Beng-sun S; Beder S; Kayacan O
Respir Med; 2001 Oct; 95(10):811-6. PubMed ID: 11601747
[TBL] [Abstract][Full Text] [Related]
4. Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
Hahn DL
Ann Allergy Asthma Immunol; 1999 Oct; 83(4):271-88, 291; quiz 291-2. PubMed ID: 10541419
[TBL] [Abstract][Full Text] [Related]
5. Impaired innate immune alveolar macrophage response and the predilection for COPD exacerbations.
Berenson CS; Kruzel RL; Eberhardt E; Dolnick R; Minderman H; Wallace PK; Sethi S
Thorax; 2014 Sep; 69(9):811-8. PubMed ID: 24686454
[TBL] [Abstract][Full Text] [Related]
6. The TGF-beta-pseudoreceptor BAMBI is strongly expressed in COPD lungs and regulated by nontypeable Haemophilus influenzae.
Drömann D; Rupp J; Rohmann K; Osbahr S; Ulmer AJ; Marwitz S; Röschmann K; Abdullah M; Schultz H; Vollmer E; Zabel P; Dalhoff K; Goldmann T
Respir Res; 2010 May; 11(1):67. PubMed ID: 20513241
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between chronic obstructive pulmonary disease and Chlamydiae pneumoniae infection].
Zhao YN; Zhao MW; Pei F; Li XY; Yao WZ
Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):333-7. PubMed ID: 15182501
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between Chlamydia pneumoniae infection and chronic obstructive pulmonary disease].
Tang LF; Wang DF; Cao LQ; Wu XD; Lü J; Yu FF
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Oct; 33(10):1072-4. PubMed ID: 23290855
[TBL] [Abstract][Full Text] [Related]
9. Imbalanced secretion of IL-1beta and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients.
Rupp J; Kothe H; Mueller A; Maass M; Dalhoff K
Eur Respir J; 2003 Aug; 22(2):274-9. PubMed ID: 12952260
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immune response associated with Chlamydia pneumoniae infection in atherosclerotic patients.
El Yazouli L; Seghrouchni F; Hejaji H; Bouazza M; Alami AA; Dakka N; Radouani F
Microb Pathog; 2020 Feb; 139():103860. PubMed ID: 31707079
[TBL] [Abstract][Full Text] [Related]
11. Role of toll-like receptors in immune responses to chlamydial infections.
Joyee AG; Yang X
Curr Pharm Des; 2008; 14(6):593-600. PubMed ID: 18336303
[TBL] [Abstract][Full Text] [Related]
12. Systematic Infection of Chlamydia Pneumoniae.
Ma Y; Sun J; Che G; Cheng H
Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975489
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of IL-17A/F from human lung tissue explants with cigarette smoke exposure: implications for COPD.
Chang Y; Al-Alwan L; Alshakfa S; Audusseau S; Mogas AK; Chouiali F; Nair P; Baglole CJ; Hamid Q; Eidelman DH
Respir Res; 2014 Nov; 15(1):145. PubMed ID: 25427574
[TBL] [Abstract][Full Text] [Related]
14. The association between serological features of chronic Chlamydia pneumoniae infection and markers of systemic inflammation and nutrition in COPD patients.
Paplińska-Goryca M; Rubinsztajn R; Nejman-Gryz P; Przybyłowski T; Krenke R; Chazan R
Scand J Clin Lab Invest; 2017 Dec; 77(8):644-650. PubMed ID: 29069917
[TBL] [Abstract][Full Text] [Related]
15. [Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma].
Azzouzi N; Elhataoui M; Bakhatar A; Takourt B; Benslimane A
Ann Biol Clin (Paris); 2005; 63(2):179-84. PubMed ID: 15771975
[TBL] [Abstract][Full Text] [Related]
16. [Signs of active infection with Chlamydia pneumoniae in patients with coronary heart disease].
Hrubá D; Roubalová K; Kraml P; Andĕl M
Cas Lek Cesk; 2004; 143(12):830-5. PubMed ID: 15730214
[TBL] [Abstract][Full Text] [Related]
17. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.
Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225
[TBL] [Abstract][Full Text] [Related]
18. Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants.
Pomerenke A; Lea SR; Herrick S; Lindsay MA; Singh D
Int J Chron Obstruct Pulmon Dis; 2016; 11():2409-2417. PubMed ID: 27729782
[TBL] [Abstract][Full Text] [Related]
19. Chlamydophila pneumoniae infection and COPD: more evidence for lack of evidence?
Papaetis GS; Anastasakou E; Orphanidou D
Eur J Intern Med; 2009 Oct; 20(6):579-85. PubMed ID: 19782917
[TBL] [Abstract][Full Text] [Related]
20. Alveolar epithelial cells type II are major target cells for C. pneumoniae in chronic but not in acute respiratory infection.
Rupp J; Droemann D; Goldmann T; Zabel P; Solbach W; Vollmer E; Branscheid D; Dalhoff K; Maass M
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):197-203. PubMed ID: 15196568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
